Brief: Else Nutrition Successfully Completes First Production Trial Run Of Its Novel, Plant-Based Infant Formula
13/10/2021 12:07
Oct 13 (Reuters) - Else Nutrition Holdings Inc BABY.V :
* ELSE NUTRITION SUCCESSFULLY COMPLETES FIRST PRODUCTION
TRIAL RUN
OF ITS NOVEL, PLANT-BASED INFANT FORMULA
Source text for Eikon: ID:nGNX8G5LRw
Further company coverage: BABY.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Else Nutrition Holdings
See all newsBrief: Else Nutrition Pursuing Parallel Listing On Canadian Securities Exchange To Ensure Market Continuity
Canada's Else Nutrition Q1 revenue falls on supply issues
Brief: Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
Brief: Else Nutrition Announces Appointment Of Natie Zilberberg As Chief Financial Officer
Brief: Else Nutrition Achieves Transformative Operational and Financial Progress in 2025